Metagenomi, Inc. (NASDAQ: MGX) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $10.00 price target on the stock.
Metagenomi, Inc. (NASDAQ: MGX) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. They now have a $6.00 price target on the stock, down previously from $16.00.
Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems [Yahoo! Finance]
Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems
Metagenomi to Present at Upcoming Scientific Meetings